RE:Infuz20 process is only one to offer shelf stability....hipgnosis wrote: Sproutly is way ahead of the game offering the tech that any major player in the pharma / beverage space will demand.
They have just entered into research collabration with Trace Research Institute to meet the challenge
that the global industry faces when it comes to shelf life and the ability to accurately measure CBD when they are formulated into beverages.
The JV’s will be unprecedented because they are so far ahead with delivering exactly what this multi billion dollar industry will demand.
Don’t take my word for it... read all about it with today’s press release:
https://mailchi.mp/d6987f9de16d/press-release-infusion-biosciences-and-trace-research-institute-announce-research-collaboration?e=4919d7d0ee
Dude trace is in the USA ... another company owns the rights to the app process down there not sproutly but yet there collaborating and testing the product in a country where they shouldn’t be.
not good to me , what if that other company that owns the license rights to the app process get winds and drops a lawsuit.......... Sproutly should be staying in a country where they have the license rights for.
Why not news on clones ? They should have been planted by now just wasting time and coming up with this .... not look good. No big jv or no big companies want touch this , I’m still wondering........
https://traceanalytics.com/. Look at that company lol ..... it’s crust.
i really don’t understand, if this is game changing tech but they can’t even get a partnership with a medicore company .... and why the hell they using the app in a country they don’t have the license rights for ??? Boggling my mind the decision sproutly is making ...
Again maybe I’m wrong but I don’t think soo . They should have stayed in Canada not gone to the USA . Remember sproutly does NOT own the license rights to use the app tech down there ....
Just horrible decisions to me.